Lysionotin attenuates Staphylococcus aureus pathogenicity by inhibiting α-toxin expression

[1]  Xuming Deng,et al.  Curcumin protects mice from Staphylococcus aureus pneumonia by interfering with the self-assembly process of α-hemolysin , 2016, Scientific Reports.

[2]  S. Tan,et al.  Alexander Fleming (1881-1955): Discoverer of penicillin. , 2015, Singapore medical journal.

[3]  Xiaodi Niu,et al.  Baicalin protects mice from Staphylococcus aureus pneumonia via inhibition of the cytolytic activity of α-hemolysin. , 2012, The Journal of infectious diseases.

[4]  Xuming Deng,et al.  Capsaicin Protects Mice from Community-Associated Methicillin-Resistant Staphylococcus aureus Pneumonia , 2012, PloS one.

[5]  A. Prince,et al.  Immunopathogenesis of Staphylococcus aureus pulmonary infection , 2012, Seminars in Immunopathology.

[6]  H. Li,et al.  Chrysin protects mice from Staphylococcus aureus pneumonia , 2011, Journal of applied microbiology.

[7]  V. Sperandio,et al.  Anti-virulence strategies to combat bacteria-mediated disease , 2010, Nature Reviews Drug Discovery.

[8]  M. Falagas,et al.  Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia , 2009, European Respiratory Journal.

[9]  S. Escaich.  Antivirulence as a new antibacterial approach for chemotherapy. , 2008, Current opinion in chemical biology.

[10]  F. Lowy,et al.  Pathogenesis of methicillin-resistant Staphylococcus aureus infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  O. Schneewind,et al.  Vaccine protection against Staphylococcus aureus pneumonia , 2008, The Journal of experimental medicine.

[12]  O. Schneewind,et al.  Surface Proteins and Exotoxins Are Required for the Pathogenesis of Staphylococcus aureus Pneumonia , 2006, Infection and Immunity.

[13]  M. Kollef,et al.  Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. , 2005, Chest.

[14]  T. Fraser,et al.  The emergence of methicillin-resistant Staphylococcus aureus in the community. , 2005, Cleveland Clinic journal of medicine.

[15]  Y. Kamio,et al.  Cooperative Assembly of β-Barrel Pore-Forming Toxins , 2004 .

[16]  R. Wunderink,et al.  Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. , 2003, Chest.

[17]  A. Suksamrarn,et al.  Antimycobacterial and antioxidant flavones fromLimnophila geoffrayi , 2003, Archives of pharmacal research.

[18]  Ji-wu Chen,et al.  Structure-activity relationship of natural flavonoids in hydroxyl radical-scavenging effects. , 2002, Acta pharmacologica Sinica.

[19]  J. Pittet,et al.  Alpha-Toxin Damages the Air-Blood Barrier of the Lung in a Rat Model of Staphylococcus aureus-Induced Pneumonia , 1999, Infection and Immunity.

[20]  J. Hacker,et al.  Effects of Subinhibitory Concentrations of Antibiotics on Alpha-Toxin (hla) Gene Expression of Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureusIsolates , 1998, Antimicrobial Agents and Chemotherapy.

[21]  F. Lowy,et al.  Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus. , 2014, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[22]  M. O'Reilly,et al.  Regulation of exoprotein gene expression in Staphylococcus aureus by agr , 2004, Molecular and General Genetics MGG.

[23]  E. Gouaux.  alpha-Hemolysin from Staphylococcus aureus: an archetype of beta-barrel, channel-forming toxins. , 1998, Journal of structural biology.

[24]  E. Gouaux.  α-Hemolysin fromStaphylococcus aureus:An Archetype of β-Barrel, Channel-Forming Toxins , 1998 .